GlassScriptPhysician profile
Blaise E Smyth
NPI 1588761563
$1,594.05
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $400 · 2023: $703 · 2024: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $393.03 | 2022-2024 | Synchromedii, Intellis Adaptivestim |
| Tersera Therapeutics LLC | $181.24 | 2023-2024 | Prialt |
| Pacira Pharmaceuticals Incorporated | $160.80 | 2023-2024 | Iovera, Zilretta |
| Bioventus LLC | $153.68 | 2022 | |
| Curonix LLC | $123.14 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $118.66 | 2022-2024 | Ztlido |
| Boston Scientific Corporation | $115.93 | 2021 | |
| Vertos Medical, INC. | $60.27 | 2023 | Mild Device Kit |
| Pfizer INC. | $53.48 | 2021 | |
| Abbvie INC. | $51.69 | 2023-2024 | |
| Allergan, INC. | $49.70 | 2021 | |
| Painteq LLC | $40.20 | 2023 | Painteq |
| Relievant Medsystems, INC. | $26.60 | 2021-2022 | |
| Nevro Corp. | $19.32 | 2022 | |
| Spr Therapeutics, INC | $16.53 | 2023 | Sprint Pns System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $16.23 | 2023 | Belbuca |
| Merck Sharp & Dohme LLC | $13.55 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaise Smyth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.